Drug Shortage Report for SODIUM BICARBONATE INJECTION USP

Last updated on 2023-02-25 History
Report ID 182958
Drug Identification Number 02516225
Brand name SODIUM BICARBONATE INJECTION USP
Common or Proper name Sodium Bicarbonate Injection USP
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) SODIUM BICARBONATE
Strength(s) 84MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10x50mL
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-02-01
Estimated end date 2023-03-10
Actual end date 2023-02-24
Shortage status Resolved
Updated date 2023-02-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2023-02-25 English Compare
v9 2023-02-24 French Compare
v8 2023-02-24 English Compare
v7 2023-02-24 French Compare
v6 2023-02-24 English Compare
v5 2023-02-02 English Compare
v4 2023-02-01 French Compare
v3 2023-02-01 English Compare
v2 2023-02-01 French Compare
v1 2023-02-01 English Compare

Showing 1 to 10 of 10